PLOD1 and hypogonadism: Although rare, male patients with X-ALD may present with hypogonadism with normal or reduced testosterone and elevated luteinizing hormone (LH) levels, likely due to VLCFA toxicity on testicular Sertoli and Leydig cells and potential androgen receptor resistance (39–41).